FDA clears Parkinson's disease drug from Acadia of new safety concerns

FDA clears Parkinson's disease drug from Acadia of new safety concerns  The San Diego Union-Tribune FDA: No Evidence Linking Pimavanserin to Parkinson Patient Deaths  MD Magazine (pimavanserin) for Patients with Hallucinations and Delusions Associated with Parkinson's Disease Psychosis  Business Wire (press release)Full coverage

(CLICK HERE TO READ AND SEE MORE)